Arabic Arabic English English French French German German
dark

Genenta to Appoint Richard Slansky as CFO and Anthony Marucci as Board Member

Genenta Science, a clinical-stage biotechnology company pioneering the development of a hematopoietic stem cell gene therapy for cancer, announces that Richard Slansky is appointed as Chief Financial Officer and proposes Anthony Marucci as independent member of the Board of Directors. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

A comprehensive review of the antiviral potential of algal metabolites.

Next Post

Study Investigates the Ability of Masimo PVi® to Predict Preload Responsiveness in Patients On Nasal High-Flow Therapy

Related Posts
Total
0
Share